TSA allows injectable medications through security with appropriate documentation
Your provider may recommend: Shorter time at the 2.5 mg initiation dose (3 weeks instead of 4) More aggressive titration to reach therapeutic levels sooner Targeting higher maintenance doses (12.5 to 15 mg) from the outset Closer monitoring of side effects to balance speed with tolerance The microdosing alternative for sensitive switchers Not everyone needs or wants to follow the standard titration
Injection Site Reactions Because tirzepatide is administered subcutaneously (under the skin), injection site reactions are relatively common: Redness, itching, or swelling at the injection site Minor bruising or tenderness Warmth or mild discomfort These reactions are usually mild and self-limiting
Affecting gut motility This refers to how quickly food moves through the digestive system
They are the most prevalent type of headache, affecting individuals of all ages
Gastrointestinal issues often improve with continued use, but monitoring is crucial